相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Levetiracetam-induced thrombocytopenia among inpatients: A retrospective study
Kinshuk Sahaya et al.
EPILEPSIA (2010)
Prospective, Randomized, Single-Blinded Comparative Trial of Intravenous Levetiracetam Versus Phenytoin for Seizure Prophylaxis
Jerzy P. Szaflarski et al.
NEUROCRITICAL CARE (2010)
Probability of Pharmacodynamic Target Attainment With Standard and Prolonged-Infusion Antibiotic Regimens for Empiric Therapy in Adults With Hospital-Acquired Pneumonia
Aryun Kim et al.
CLINICAL THERAPEUTICS (2009)
Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus
Joris W. F. Uges et al.
EPILEPSIA (2009)
Epilepsy after head injury: An overview
Daniel H. Lowenstein
EPILEPSIA (2009)
Safety and Efficacy of Levetiracetam for Critically Ill Patients with Seizures
Karen M. Nau et al.
NEUROCRITICAL CARE (2009)
Anticonvulsant Use and Outcomes After Intracerebral Hemorrhage
Andrew M. Naidech et al.
STROKE (2009)
SHOULD LEVETIRACETAM REPLACE PHENYTOIN FOR SEIZURE PROPHYLAXIS AFTER NEUROSURGERY?
Nathan B. Fountain
EPILEPSY CURRENTS (2009)
Incidence of seizures in the acute phase of stroke: A population-based study
Jerzy P. Szaflarski et al.
EPILEPSIA (2008)
Intravenous levetiracetam:: Treatment experience with the first 50 critically ill patients
Stephan Rueegg et al.
EPILEPSY & BEHAVIOR (2008)
Electrographic seizures and periodic discharges after intracerebral hemorrhage
J. Claassen et al.
NEUROLOGY (2007)
Effect of age and comedication on levetiracetam pharmacokinetics and tolerability
Lawrence J. Hirsch et al.
EPILEPSIA (2007)
Pharmacokinetics of levetiracetam in infants and young children with epilepsy
Tracy A. Glauser et al.
EPILEPSIA (2007)
Pharmacodynamic target attainment of six β-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004
C. Andrew DeRyke et al.
PHARMACOTHERAPY (2007)
Levetiracetam use in critically ill patients
Jerzy P. Szaflarski et al.
NEUROCRITICAL CARE (2007)
Levetiracetam intravenous infusion: A randomized, placebo-controlled safety and pharmacokinetic study
Steven Ramael et al.
EPILEPSIA (2006)
Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects
S Ramael et al.
CLINICAL THERAPEUTICS (2006)
Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage
J Claassen et al.
NEUROCRITICAL CARE (2006)
Clinical pharmacokinetics of levetiracetam
PN Patsalos
CLINICAL PHARMACOKINETICS (2004)
Therapeutic drug monitoring of the newer antiepileptic drugs
SI Johannessen et al.
THERAPEUTIC DRUG MONITORING (2003)
Acute seizures after intracerebral hemorrhage - A factor in progressive midline shift and outcome
PM Vespa et al.
NEUROLOGY (2003)
Pharmacokinetic study of levetiracetam in children
JM Pellock et al.
EPILEPSIA (2001)
A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
T Betts et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2000)
分享论文
